| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.078 | 0.6 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |